|
Volumn 12, Issue 9, 2012, Pages 2269-2270
|
Costimulation blockade - A double-edged sword?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABATACEPT;
BASILIXIMAB;
BELATACEPT;
CD28 ANTIGEN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4LG;
FC RECEPTOR;
INTERLEUKIN 2;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
AUTOIMMUNE DISEASE;
CARDIAC GRAFT REJECTION;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CELL SURVIVAL;
CELLULAR IMMUNITY;
COSTIMULATION BLOCKADE;
CYTOKINE PRODUCTION;
DRUG EFFICACY;
EDITORIAL;
IMMUNOMODULATION;
IMMUNOSTIMULATION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
ANIMALS;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
IMMUNOCONJUGATES;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-2;
T-LYMPHOCYTES, REGULATORY;
THYMUS GLAND;
|
EID: 84865588835
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/j.1600-6143.2012.04185.x Document Type: Editorial |
Times cited : (3)
|
References (6)
|